Cargando…
Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma
BACKGROUND: Cell-free DNA (cfDNA) is being explored as biomarker for non-invasive diagnosis of cancer. We aimed to establish a cfDNA-based DNA methylation marker panel to differentially diagnose papillary thyroid carcinoma (PTC) from benign thyroid nodule (BTN). METHODS: 220 PTC- and 188 BTN patient...
Autores principales: | Hong, Shubin, Lin, Bo, Xu, Minjie, Zhang, Quan, Huo, Zijun, Su, Mingyang, Ma, Chengcheng, Liang, Jinyu, Yu, Shuang, He, Qiye, Su, Zhixi, Li, Yanbing, Liu, Rui, Guo, Zhuming, Lv, Weiming, Xiao, Haipeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996242/ https://www.ncbi.nlm.nih.gov/pubmed/36868052 http://dx.doi.org/10.1016/j.ebiom.2023.104497 |
Ejemplares similares
-
Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability
por: Hong, Shubin, et al.
Publicado: (2022) -
Genetic alterations in cfDNA of benign and malignant thyroid nodules based on amplicon-based next-generation sequencing
por: Cao, Siting, et al.
Publicado: (2020) -
TET1 is a Tumor Suppressor That Inhibits Papillary Thyroid Carcinoma Cell Migration and Invasion
por: Yu, Shuang, et al.
Publicado: (2020) -
MiR-195 Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting CCND1 and FGF2
por: Yin, Yali, et al.
Publicado: (2017) -
Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000
por: Sun, Jin, et al.
Publicado: (2023)